Dr. Hu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3601 Pierce Ave
Nashville, TN 37232Phone+1 615-936-2000
Education & Training
Massachusetts General HospitalPost-Doctoral Fellowship, 1999 - 2005
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1998 - 2001
Johns Hopkins UniversityResidency, Internal Medicine, 1995 - 1998
New York University School of MedicineClass of 1995
Harvard UniversityA.B., Biology, cum laude, 1981 - 1985
Certifications & Licensure
TN State Medical License 2016 - 2025
MI State Medical License 2005 - 2018
MA State Medical License 1998 - 2007- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Elected Member The American Society for Clinical Investigation, 2011
Publications & Presentations
PubMed
- 217 citationsCloning of a novel, ubiquitously expressed human phosphatidylinositol 3-kinase and identification of its binding site on p85Patrick J. Hu, Anna Mondino, Edward Y. Skolnik, Joseph Schlessinger
Molecular and Cellular Biology. 1993-12-01 - 15 citationsVav: A potential link between tyrosine kinases and Ras‐like GTPases in hematopoietic cell signalingPatrick J. Hu, Ben Margolis, Joseph Schlessinger
Bioessays. 1993-03-01 - 296 citationsTyrosine phosphorylation of vav proto-oncogene product containing SH2 domain and transcription factor motifs.B. Margolis, Patrick J. Hu, Shulamit Katzav, W. Li, Janet M. Oliver
Nature. 1992-03-05
Journal Articles
- Insulin/insulin-like growth factor signaling in C. elegansMurphy CT, Hu PJ, Wormbook
Press Mentions
A Common Insulin Signaling Pathway Across Cancer and DiabetesDecember 4th, 2019
Grant Support
- FoxO Phosphorylation in the Control of C. elegans Life SpanNational Institute on Aging2012–Present
- EAK-7, a Novel Regulator of FoxO Tumor SuppressorsAmerican Cancer Society2010–Present
- Genetic Modifiers of In Vivo Hypoxia ResistanceAmerican Heart Association2011–2012
- Novel Regulators Of FOXO Transcription FactorsNational Institute Of Diabetes And Digestive And Kidney Diseases2008–2009
- Genetic Analysis Of DAF-18/PTEN Signaling In C.ElegansNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2006
- Genetic Analysis Of DAF-18/PTEN Signaling In C.ElegansNational Institute Of Diabetes And Digestive And Kidney Diseases2002–2004
Professional Memberships
- American Society of Clinical InvestigationMember
- Genetics Society of AmericaMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
